Abstract
Using the concept of effective dose equivalent, H E, it is shown that a knowledge of the detailed biodistribution data in most organs and tissues taking up 99mTc labelled radiopharmaceuticals is unnecessary for the calculation of radiation risk. Reasonably precise dosimetry (±25%) can be obtained from urine excretion data alone providing there is no significant uptake within the gonads or the thyroid. Special attention should only be paid to absorbed dose measurements in red bone marrow, skin, lungs, gonads and thyroid, with the greatest attention directed toward the retention and dosimetric aspects of radioactivity in the latter two organs. An example H E calculation for 99mTc labelled d,1-HMPAO is presented to illustrate the importance of these specific five organs to radiation risk.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Huda W (1986) Nuclear medicine dose equivalent: A method for determination of radiation risk. J Nuc Med Tech 14:199–201
Huda W, Sandison GA (1986) The use of effective dose equivalent, H E as a risk parameter in computed tomography. Br J Radiology 59:1236–1238
Huda W, Sandison GA (1988) Computing remainder dose equivalent for H E. Health Physics 55:1011–1013
Huda W, Sandison GA, Wylie D (1987) The effective dose equivalent, H E, in chest x-ray dosimetry. Proceedings of the Chest Imaging Conference, Madison, USA, pp 416–423
ICRP (1975) International Commission on Radiological Protection, Report of the Task Group on Reference Man, ICRP Publication 23. Pergamon Press, Oxford
ICRP (1977) International Commission on Radiological Protection, Recommendations of the International Commission on Radiological Protection. ICRP Publication 26 Pergamon Press, Oxford
ICRP (1979) International Commission on Radiological Protection, Limits for intakes of radionuclides by workers. ICRP Publication 30. Annals of the ICRP Vol. 2 No. 3/4, Pergamon Press, Oxford
ICRP (1985) International Commission on Radiological Protection Statement from the 1985 Paris meeting of the International Commission on Radiological Protection. Phys Med Biol 30:863–864
ICRU (1979) International Commission on Radiation Units and Measurements, Methods of Assessment of Absorbed Dose in Clinical Use of Radionuclides, ICRU Report 32 (International Commission on Radiation Units and Measurements, Bethesda, Maryland)
Johansson L, Mattsson S, Nosslin B (1984) Effective dose equivalent from radiopharmaceuticals. Eur J Nucl Med 9:485–489
Kereiakes JG, Rosenstein M (1980) Handbook of radiation doses in nuclear medicine and diagnostic x-ray. CRC Press, Boca Raton, Florida
Lowe D (1988) Dosimetry of 99mTc Pyrophosphate. M.Sc. Thesis University of Manitoba, Canada
Neirinckx RD, Canning LR, Piper IM, Nowotnik DP, Pickett RD, Holmes RA, Volkert WA, Forster AM, Weisner PS, Marriott JA, Chaplin SB (1987) Technetium — 99m d,1-HM-PAO: A new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 28:191–202
Rannikko S, Sesvomaa A, Ermskov I, Masarskii L, Saltahova L, Razamnaya M, Nikitin V (1987) Calculation of the estimated dose equivalent (S E) due to x-ray diagnostic examinations. Estimates of the S E in Finland. Health Physics 53:31–36
Snyder WS, Ford MR, Warner GG, Fisher HL Jr (1969) Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. J Nucl Med (Suppl 3, Pamphlet No. 5)
Snyder WS, Ford MR, Warner GG, Watson SB (1975) “S”, absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD pamphlet No. 11, New York, Society of Nuclear Medicine
UNSCEAR (1982) United Nations Scientific Committee on the Effects of Atomic Radiations. Report to the General Assembly (New York: UN)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Huda, W., Sandison, G.A. The use of the effective dose equivalent, H E, for 99mTc labelled radiopharmaceuticals. Eur J Nucl Med 15, 174–179 (1989). https://doi.org/10.1007/BF00253789
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00253789